[HTML][HTML] Importance of potential new biomarkers in patient with serouse ovarian cancer
A Cymbaluk-Płoska, K Chudecka, A Chudecka-Głaz… - Diagnostics, 2021 - mdpi.com
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …
Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
A Cymbaluk-Płoska, K Chudecka… - …, 2021 - search.proquest.com
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …
Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
A Cymbaluk-Płoska, K Chudecka… - Diagnostics (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …
Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer.
A Cymbaluk-Płoska, K Chudecka… - Diagnostics (2075 …, 2021 - search.ebscohost.com
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …
[HTML][HTML] Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
A Cymbaluk-Płoska, K Chudecka, A Chudecka-Głaz… - Diagnostics, 2021 - ncbi.nlm.nih.gov
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …
Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer.
A Cymbaluk-Płoska, K Chudecka… - Diagnostics (Basel …, 2021 - europepmc.org
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …
[PDF][PDF] Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer. Diagnostics 2021, 11, 1026
A Cymbaluk-Płoska, K Chudecka, A Chudecka-Głaz… - 2021 - rv-laboratory.com
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our
study, we compare a number of proteins from different effector pathways to assess their …
study, we compare a number of proteins from different effector pathways to assess their …